TD Bank Group Invests $1 Million to Advance Research in Women’s Brain Health and Menopause Care

Skip to Content News Archives Economy Energy Oil & Gas Renewables Electric Vehicles Mining Commodities Agriculture Real Estate Mortgages Mortgage Rates Finance Banking Insurance Fintech Cryptocurrency Work Wealth Smart Money Wealth Management Investor Personal Finance Family Finance Retirement Taxes High Net Worth FP Comment Executive Women Puzzmo Newsletters Financial Times Business Essentials More Innovation Information Technology FP500 Podcasts Small Business Lives Told Tails Told Shopping Financial Post Store Obituaries Place a Notice Advertising Advertising With Us Advertising Solutions Postmedia Ad Manager Sponsorship Requests Classifieds Place a Classifieds ad Working Profile Settings My Subscriptions Saved Articles My Offers Newsletters Customer Service FAQ News Economy Energy Mining Real Estate Finance Work Wealth Investor FP Comment Executive Women Puzzmo Newsletters Financial Times Business Essentials This advertisement has not loaded yet, but your article continues below.HomeGlobeNewswireThis section is The content in this section is supplied by GlobeNewswire for the purposes of distributing press releases on behalf of its clients. Postmedia has not reviewed the content. by GlobeNewswire TD Bank Group Invests $1 Million to Advance Research in Women's Brain Health and Menopause CareAuthor of the article: You can save this article by registering for free here. Or sign-in if you have an account.The Weston and O'Born Centre for Mature Women's Health at Mount Sinai Hospital aims to transform the way women receive care across the lifetime by advancing access to research, education and care. GNWTD’s donation to Sinai Health Foundation will expand a novel study investigating whether menopausal hormone therapy can help address migraine and brain fog symptoms experienced during menopause.THIS CONTENT IS RESERVED FOR SUBSCRIBERS ONLYSubscribe now to read the latest news in your city and across Canada.Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman, and others.Daily content from Financial Times, the world's leading global business publication.Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.Daily puzzles, including the New York Times Crossword.SUBSCRIBE TO UNLOCK MORE ARTICLESSubscribe now to read the latest news in your city and across Canada.Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman and others.Daily content from Financial Times, the world's leading global business publication.Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.Daily puzzles, including the New York Times Crossword.REGISTER / SIGN IN TO UNLOCK MORE ARTICLESCreate an account or sign in to continue with your reading experience.Access articles from across Canada with one account.Share your thoughts and join the conversation in the comments.Enjoy additional articles per month.Get email updates from your favourite authors.THIS ARTICLE IS FREE TO READ REGISTER TO UNLOCK.Create an account or sign in to continue with your reading experience.Access articles from across Canada with one accountShare your thoughts and join the conversation in the commentsEnjoy additional articles per monthGet email updates from your favourite authorsSign In or Create an AccountToronto, ON, July 27, 2026 (GLOBE NEWSWIRE) — TD Bank Group (TD) has made a $1-million commitment to support research aimed at improving health outcomes and quality of life for women in midlife. This investment will fund an expanded study at Sinai Health’s Weston and O’Born Centre for Mature Women’s Health to investigate whether menopausal hormone therapy (MHT) can help alleviate migraine and brain fog symptoms associated with menopause. Hormonal fluctuations during menopause can lead to debilitating symptoms, including migraines and brain fog, significantly impacting women’s daily lives. Despite the prevalence of these concerns, evidence-based treatment options tailored specifically to menopause-related migraine and cognitive symptoms remain limited. Fuelled by TD’s donation, the study will use advanced brain imaging and neuropsychological testing to determine if MHT can safely and effectively reduce these symptoms, potentially leading to more personalized and safer menopause treatments. Get the latest headlines, breaking news and columns.By signing up you consent to receive the above newsletter from Postmedia Network Inc.A welcome email is on its way. If you don't see it, please check your junk folder.The next issue of Top Stories will soon be in your inbox.We encountered an issue signing you up. Please try againThe Weston and O’Born Centre for Mature Women’s Health is home to an internationally recognized Mature Women’s Health Program that supports thousands of women from across Ontario each year. As one of the only academic centres in the world to make menopause and women’s health a key strategic priority, Sinai Health is committed to integrating research, education and clinical care to address the unique health needs of women during midlife and beyond. “Menopause affects millions of women, yet too many continue to navigate it without enough support. At TD, we believe progress starts with understanding people’s experiences. That’s why we’re proud to support Sinai Health’s research to help address an area of women’s health that has been overlooked for too long. We’re also honoured to build on the legacy of Hilary Weston, whose generosity and unwavering belief that women deserve care tailored to their unique needs helped shape the Weston and O’Born Centre for Mature Women’s Health. We hope our contribution helps create a future where more women feel supported to access the care they deserve,” says Anna Iacobelli, Senior Vice President, Metro West Region, TD Bank Group. TD’s donation will help Sinai Health to lay the foundation for more precision, evidence-based menopause care that enhances quality of life and protects long-term brain health. “Historic gaps in research have left women without effective treatment options, perpetuating avoidable suffering,” says Dr. Marie Christakis, Study Co-Lead and Clinical Lead at the Weston and O’Born Centre for Mature Women’s Health, Sinai Health. “Our work aims to unlock insights that can meaningfully improve cognitive health and brain function in women throughout the menopause transition. We’re deeply grateful to TD for enabling us to explore treatment options that could enhance quality of life for millions of women during this critical life stage.” TD has a longstanding history of supporting health initiatives at Sinai Health that address the health challenges our society faces. This latest contribution underscores TD’s commitment to advancing health-care solutions that address underserved populations and pressing medical challenges. About Sinai Health Foundation This advertisement has not loaded yet.This advertisement has not loaded yet, but your article continues below.Sinai Health Foundation takes the vision of Sinai Health’s physicians, clinicians, scientists and health-care providers and helps turn it into reality. Philanthropy is essential for advancing research, care, and outcomes for those facing cancer, a high-risk pregnancy, stroke recovery, and other conditions and diseases. Thanks to philanthropy, Sinai Health Foundation helps fund world-class facilities and offers patients access to integrated and exceptional care, tailored to meet their unique needs. Learn more at supportsinai.ca. Emily Wiles Sinai Health Foundation 647-797-4609 emily.wiles@sinaihealthfoundation.ca Notice for the Postmedia NetworkThis website uses cookies to personalize your content (including ads), and allows us to analyze our traffic. Read more about cookies here. By continuing to use our site, you agree to our Terms of Use and Privacy Policy.